10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025
10x Genomics (TXG), a leader in single cell and spatial biology, has scheduled its first quarter 2025 financial results announcement for May 8, 2025, after market close. The company will host a conference call and webcast for analysts and investors at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day.
The financial results will be accessible through a news release on the company's website before the conference call. Interested parties can access the live audio webcast through the 'Investors' section at investors.10xgenomics.com, with a replay available for at least 45 days following the event.
10x Genomics (TXG), leader nella biologia cellulare singola e spaziale, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per l'8 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call e una webcast per analisti e investitori alle 13:30 ora del Pacifico / 16:30 ora dell'Est lo stesso giorno.
I risultati finanziari saranno disponibili tramite un comunicato stampa sul sito web dell'azienda prima della conference call. Gli interessati potranno seguire la diretta audio webcast nella sezione 'Investitori' su investors.10xgenomics.com, con la possibilità di riascoltare la registrazione per almeno 45 giorni dopo l'evento.
10x Genomics (TXG), líder en biología celular única y espacial, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 8 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada de conferencia y una transmisión en vivo para analistas e inversores a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este ese mismo día.
Los resultados financieros estarán disponibles mediante un comunicado de prensa en el sitio web de la empresa antes de la llamada de conferencia. Las personas interesadas podrán acceder a la transmisión de audio en vivo a través de la sección 'Inversores' en investors.10xgenomics.com, con una repetición disponible al menos 45 días después del evento.
10x Genomics (TXG)는 단일 세포 및 공간 생물학 분야의 선두주자로, 2025년 1분기 실적 발표를 2025년 5월 8일 장 마감 후에 예정했습니다. 회사는 같은 날 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 애널리스트 및 투자자를 위한 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
재무 결과는 컨퍼런스 콜 전에 회사 웹사이트의 뉴스 릴리스를 통해 확인할 수 있습니다. 관심 있는 분들은 investors.10xgenomics.com의 'Investors' 섹션에서 실시간 오디오 웹캐스트에 접속할 수 있으며, 이벤트 후 최소 45일 동안 다시 듣기가 가능합니다.
10x Genomics (TXG), leader en biologie cellulaire unique et spatiale, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 8 mai 2025, après la clôture du marché. La société organisera une conférence téléphonique et une webdiffusion pour les analystes et investisseurs à 13h30 heure du Pacifique / 16h30 heure de l'Est ce même jour.
Les résultats financiers seront accessibles via un communiqué de presse sur le site internet de l'entreprise avant la conférence téléphonique. Les personnes intéressées pourront accéder à la webdiffusion audio en direct via la section « Investisseurs » sur investors.10xgenomics.com, avec une rediffusion disponible pendant au moins 45 jours après l'événement.
10x Genomics (TXG), ein führendes Unternehmen im Bereich Einzelzell- und Raumbiologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 8. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Östlicher Zeit eine Telefonkonferenz und Webcast für Analysten und Investoren abhalten.
Die Finanzergebnisse werden vor der Telefonkonferenz über eine Pressemitteilung auf der Firmenwebsite zugänglich sein. Interessierte können den Live-Audio-Webcast über den Bereich 'Investoren' auf investors.10xgenomics.com verfolgen, wobei eine Wiederholung mindestens 45 Tage nach der Veranstaltung verfügbar sein wird.
- None.
- None.
Live audio of the webcast will be available on the "Investors" section of the company website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables, and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience, and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X (Twitter), Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-first-quarter-2025-financial-results-on-may-8-2025-302427837.html
SOURCE 10x Genomics, Inc.
FAQ
When will 10x Genomics (TXG) release Q1 2025 earnings?
What time is the 10x Genomics (TXG) Q1 2025 earnings call?
How can investors access the 10x Genomics (TXG) Q1 2025 earnings call?
How long will the 10x Genomics (TXG) Q1 2025 earnings call replay be available?
